Autopsy report · NCT04698057

Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial.

“No enrolment due to Covid-19”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Poitiers University Hospital

Sponsor type

University, hospital or other

Conditions

Febrile Neutropenia

Interventions

Placebo; Amoxicillin Clavulanate; Ciprofloxacin

Participants

0

Trials that died the same way

• Regional Anesthesia to Relief Zoster Pain
  “No enrollement and covid” (76% match in meaning)
• EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
  “No enrollment due to COVID” (74% match in meaning)
• Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate
  “Covid 19 Pandemic - Unable to enroll patients” (71% match in meaning)
• Study of the Loss of AV Synchrony at Maximum Exercise
  “No Enrollments after COVID” (71% match in meaning)
• Effects of High Caffeine Content Coffee on Blood Pressure in Young Adults
  “not possible to enroll during COVID pandemic” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.